Logo 1-1.png
Chemomab Therapeutics Announces Year End and Fourth Quarter 2024 Financial Results and Provides a Corporate Update
March 03, 2025 08:00 ET | Chemomab Therapeutics
In 2024 reported positive nebokitug Phase 2 primary sclerosing cholangitis data and aligned on a clear, efficient path to potential FDA regulatory approval
Wa'el Hashad
Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update
February 28, 2025 16:04 ET | Longeveron
Longeveron announces 2024 financial results and provides business update. Pivotal Phase 2b clinical trial achieves 90% enrollment.
Twin Peaks Logo R.png
TWIN HOSPITALITY GROUP INC. REPORTS FISCAL FOURTH QUARTER AND FULL FISCAL YEAR 2024 FINANCIAL RESULTS
February 27, 2025 16:10 ET | Twin Hospitality Group Inc.
Opened Nine Twin Peaks Lodges in 2024 Completed First Smokey Bones Conversion in September 2024 and Second Smokey Bones Conversion in February 2025 Hosting Inaugural Conference Call and Webcast...
Logo.png
FAT BRANDS INC. REPORTS FISCAL FOURTH QUARTER AND FULL FISCAL YEAR 2024 FINANCIAL RESULTS
February 27, 2025 16:05 ET | FAT Brands Inc.
Conference call and webcast today at 4:30 p.m. ET LOS ANGELES, Feb. 27, 2025 (GLOBE NEWSWIRE) -- FAT (Fresh. Authentic. Tasty.) Brands Inc. (NASDAQ: FAT) (“FAT Brands” or the “Company”) today...
FA_FullLogo_Horiz_FullColor_RGB@3x.png
First Advantage Reports Fourth Quarter and Full Year 2024 Results
February 27, 2025 06:30 ET | First Advantage Corporation
Full Year 2024 Highlights1 Revenues of $860.2 millionNet Loss of $(110.3) million, a net loss margin of (12.8)%, includes $130.5 million of expenses incurred related to the acquisition of Sterling...
Logo_Pharming_original.png
Pharming Group to report fourth quarter and full year 2024 financial results on March 13
February 27, 2025 02:00 ET | Pharming Group N.V.
Leiden, the Netherlands, February 27, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) fourth quarter and full year...
CMB.TECH_Icon_color (4).png
CMB.TECH announces Q4 2024 results
February 27, 2025 01:05 ET | CMB.TECH NV.
CMB.TECH ANNOUNCES Q4 2024 RESULTS STRONG RESULTS DESPITE SLOW MARKETS ANTWERP, Belgium, 27 February 2025 – CMB.TECH NV (“CMBT”, “CMB.TECH” or “the Company”) (NYSE: CMBT & Euronext: CMBT)...
Arcutis logo.png
Arcutis Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
February 25, 2025 16:00 ET | Arcutis Biotherapeutics, Inc.
WESTLAKE VILLAGE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Q4 2024 net product revenue for ZORYVE® (roflumilast) was $69.4 million, a 413% increase compared to Q4 of 2023 and a 55% increase...
twin peaks.jpg
Twin Hospitality Group Inc. Announces Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
February 25, 2025 08:00 ET | Twin Peaks Restaurants
DALLAS, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Twin Hospitality Group Inc. (“Twin Hospitality”) (NASDAQ: TWNP), the operating unit for the Twin Peaks and Smokey Bones restaurant brands, today announced...
Kneat Logo 300 dpi.jpg
Kneat to Announce 2024 Fourth-Quarter and Full-Year Financial Results February 26, 2025
February 24, 2025 16:17 ET | kneat.com, inc.
Kneat will announce 2024 fourth-quarter and full-year financial results after market close on February 26, 2025.